Skip to content

Effects of Advanced Glycation Endproducts on Satiety and Inflammation

Crossover Meal Study Investigating Effects of Advanced Glycation Endproducts on Satiety and Inflammation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01434407
Acronym
AGE-1
Enrollment
19
Registered
2011-09-14
Start date
2011-08-31
Completion date
2012-03-31
Last updated
2012-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Insulin Resistance, Obesity, Type 2 Diabetes

Keywords

Advanced glycation endproducts, Satiety, Obesity, Inflammation, Insulin resistance

Brief summary

The purpose of the meal study is to investigate acute effects on satiety and inflammation of advanced glycation endproducts (AGE) in healthy overweight subjects. The AGE content of the meal is affected by food preparation methods: frying/grilling versus boiling/steaming.

Interventions

Test meals with different AGE content made by different cooking methods

Sponsors

The Ministry of Science, Technology and Innovation, Denmark
CollaboratorOTHER_GOV
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy males and females between 20 and 50 years old * BMI 25-40 * Waist circumference above 88 cm for women and above 102 cm for men

Exclusion criteria

* Exercise training above 8 hour/week * Smoking * Pregnant or breast-feeding women * Post-menstrual women * Regular use of medicine (except contraceptive pills) * Previous gastric bypass surgery * Donation of blood within the last 3 months * Involvement in other clinical trials * Allergic to paraaminobenzoic acid

Design outcomes

Primary

MeasureTime frameDescription
Appetite sensationEvery 30 min up to 5 hours after test mealAppetite sensation measured by visual analogue scales
Plasma ghrelinContinuous measurement up to 5 hours after test meal
Plasma GLP-1Continuous measurements up to 5 hours after test meal
Plasma PYYContinuous measurements up to 5 hours after test meal
Plasma insulinContinuous measurements up to 5 hours after test meal
Plasma glucoseContinuous measurements up to 5 hours after test meal
Urine AGEFrom 24 hour before to 48 hour after test meal

Secondary

MeasureTime frame
ICAMContinuous measurements up to 5 hours after test meal
MIFContinuous measurements up to 5 hours after test meal
Plasma triglyceridesContinuous measurements up to 5 hours after test meal
Urine isoprostanesFrom 24 hour before to 24 hours after test meal
Plasma AGEContinuous measurements up to 48 hours after test meal
Expression of genes related to AGEContinuous measurements up to 24 hours after test meal
IL-1 betaContinuous measurements up to 5 hours after test meal
IL-6Continuous measurements up to 5 hours after test meal
TNF-alphaContinuous measurements up to 5 hours after test meal
CRPContinuous measurements up to 5 hours after test meal
VCAMContinuous measurements up to 5 hours after test meal

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026